Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooke Hayward

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Delivery|December 6, 2017
Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE studySibyl Wray, Brooke Hayward, Fernando Dangond, et al.
Advances in Therapy|September 27, 2018
Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing SurveillanceMeritxell Sabidó, Saritha Venkatesh, Brooke Hayward, et al.
Journal of Primary Health Care|March 14, 2018
Evaluation of general practice house officer attachments in Counties Manukau: insights and benefitsLyndsay Le Comte, Brooke Hayward, David Hughes, et al.
Health Literacy Research and Practice|September 15, 2020
Creating Health Literate Consumer Resources: Insights from a Professional Development ProgramBrooke Hayward, Siniva Sinclair, Margot Martin-Babin, et al.
Plos One|October 13, 2015
Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal FatAlexandra Mangili, Julian Falutz, Jean-Claude Mamputu, et al.
Multiple Sclerosis and Related Disorders|July 24, 2023
Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world dataLilyana Amezcua, Terrie Livingston, Brooke Hayward, et al.
BMC Genetics|February 21, 2004
Mapping complex traits using Random ForestsAlexandre Bureau, Josée Dupuis, Brooke Hayward, et al.
Expert Opinion on Drug Delivery|April 22, 2015
Human factors engineering and design validation for the redesigned follitropin alfa pen injection deviceMary C Mahony, Patricia Patterson, Brooke Hayward, et al.
BMC Genetics|December 14, 2004
Screening large-scale association study data: exploiting interactions using random forestsKathryn L Lunetta, L Brooke Hayward, Jonathan Segal, et al.
International Journal of MS Care|March 16, 2023
Outcomes and Health Care Service Use in Adults 50 Years or Older With and Without Multiple Sclerosis: A 6-Year Observational AnalysisLeorah Freeman, Ashlea Lucas, Jia Zhou, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Delivery|December 6, 2017
Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE studySibyl Wray, Brooke Hayward, Fernando Dangond, et al.
Advances in Therapy|September 27, 2018
Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing SurveillanceMeritxell Sabidó, Saritha Venkatesh, Brooke Hayward, et al.
Journal of Primary Health Care|March 14, 2018
Evaluation of general practice house officer attachments in Counties Manukau: insights and benefitsLyndsay Le Comte, Brooke Hayward, David Hughes, et al.
Health Literacy Research and Practice|September 15, 2020
Creating Health Literate Consumer Resources: Insights from a Professional Development ProgramBrooke Hayward, Siniva Sinclair, Margot Martin-Babin, et al.
Plos One|October 13, 2015
Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal FatAlexandra Mangili, Julian Falutz, Jean-Claude Mamputu, et al.
Multiple Sclerosis and Related Disorders|July 24, 2023
Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world dataLilyana Amezcua, Terrie Livingston, Brooke Hayward, et al.
BMC Genetics|February 21, 2004
Mapping complex traits using Random ForestsAlexandre Bureau, Josée Dupuis, Brooke Hayward, et al.
Expert Opinion on Drug Delivery|April 22, 2015
Human factors engineering and design validation for the redesigned follitropin alfa pen injection deviceMary C Mahony, Patricia Patterson, Brooke Hayward, et al.
BMC Genetics|December 14, 2004
Screening large-scale association study data: exploiting interactions using random forestsKathryn L Lunetta, L Brooke Hayward, Jonathan Segal, et al.
International Journal of MS Care|March 16, 2023
Outcomes and Health Care Service Use in Adults 50 Years or Older With and Without Multiple Sclerosis: A 6-Year Observational AnalysisLeorah Freeman, Ashlea Lucas, Jia Zhou, et al.
Pageof 5